The National Health Security Board has approved laboratory testing and medication for treating vaccine-induced immune thrombotic thrombocytopenia (VITT) under the Universal Coverage Scheme (UCS)'s benefits package. The introduction of VITT laboratory testing and...
![Thailand announces new benefits package for VITT diagnosis and treatment under Universal Coverage Scheme](https://p4h.world/app/uploads/2023/03/coronainsurance449-1.x23411.jpg)